Objectives:

1. Understand how the pathophysiology of HRS/AKI in cirrhosis serves as the framework for our clinical approach to this disease.
2. Provide treatment updates for HRS.
3. Look forward towards upcoming diagnostics and therapies for HRS.

Session date: 
Wednesday, December 13, 2017 - 4:00pm to 5:00pm
Speaker Name: 
Andrew Allegretti, MD, MSc
Location: 
UCMC S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.